Stuff that matters
Despite decades of research, Alzheimer’s disease remains a debilitating and eventually fatal dementia with no effective treatment options. More than 95 percent of Alzheimer’s disease cases have no known origin. Now, scientists from the Salk Institute have found that neurons Read more
Research on understanding the effect of extra chromosomes for conditions like Down syndrome typically involves examining what genes play a role in the symptoms of these conditions. However, researchers from Germany and the U.S. propose a new way of looking Read more
The effect of medicines on women and men can differ significantly. This also applies to the currently most promising anti-aging drug rapamycin, as researchers from the Max Planck Institute for Biology of Ageing in Cologne and University College London have Read more
For many people, being able to engage in everyday life is something they take for granted. Gaining employment, finding a place to live and pursuing travel, leisure and social activities become more about “which” movie to see rather than “if” Read more
Researchers at Johns Hopkins Medicine say they have created a laboratory-grown three-dimensional “organoid” model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop at the gastroesophageal junction (GEJ)—the point where the Read more
New research supported by the euCanSHare and HealthyCloud projects has revealed that a model combining ECG features and cardiac imaging-derived radiomics data improves the detection of AF in women. The study was published in the journal Scientific Reports. AF is Read more
An interdisciplinary team of researchers led by Indiana University bioengineer Feng Guo has developed a tool that could lead to improved cancer immunotherapy. The prototype platform facilitates automated drug screening and real-time, 3D imaging and analysis of interactions between immune Read more